Core Viewpoint - Rosen Law Firm is encouraging investors of DexCom, Inc. to secure legal counsel before the December 29, 2025 deadline for a securities class action related to alleged misleading statements and health risks associated with the company's glucose monitoring systems [2][3][6]. Group 1: Class Action Details - The class action pertains to investors who purchased DexCom securities between July 26, 2024, and September 17, 2025 [2]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A lead plaintiff must file a motion with the court by December 29, 2025, to represent other class members [4]. Group 2: Allegations Against DexCom - The lawsuit claims that DexCom made unauthorized design changes to its G6 and G7 continuous glucose monitoring systems, which compromised their reliability and posed health risks to users [6]. - Defendants allegedly overstated the enhancements and reliability of the G7 devices while downplaying the severity of the issues [6]. - The situation has led to increased regulatory scrutiny and potential legal, reputational, and financial harm for DexCom [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company [5]. - The firm was ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [5]. - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in litigation [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Stride, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][3]. Group 1: Class Action Details - Investors who purchased Stride securities between October 22, 2024, and October 28, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 12, 2026 [3]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [4]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, Stride made misleading statements about its products and services, inflating enrollment numbers and cutting staff costs beyond statutory limits [5]. - The firm claims that when the true details about Stride's operations became known, investors suffered damages [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of CarMax, Inc. to secure legal counsel before the January 2, 2026 deadline for a securities class action lawsuit related to the company's misleading statements during the class period from June 20, 2025, to November 5, 2025 [2][6]. Summary by Sections Class Action Details - Investors who purchased CarMax securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 2, 2026 [4]. Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering hundreds of millions for investors [5]. - The firm has been recognized for its leadership in securities class action settlements, achieving significant recoveries in previous years [5]. Allegations Against CarMax - The lawsuit alleges that CarMax's management made materially false and misleading statements regarding the company's growth prospects, which were overstated due to temporary market conditions [6]. - The claims suggest that when the true nature of the company's performance became known, investors suffered damages as a result of these misleading statements [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Synopsys, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Synopsys securities between December 4, 2024, and September 9, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 30, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that Synopsys made materially false and misleading statements and failed to disclose adverse facts about its business and operations during the Class Period [5]. - Specific claims include that Synopsys' focus on artificial intelligence customers negatively impacted the economics of its Design IP business and that certain strategic decisions were unlikely to yield intended results [5]. - The lawsuit asserts that these undisclosed issues had a materially negative impact on Synopsys' financial results, leading to investor damages when the true information became public [5].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of investors who purchased securities of Perrigo Company plc during the specified Class Period, highlighting the importance of securing legal counsel before the upcoming deadline for lead plaintiff applications [1][2]. Group 1: Class Action Details - The class action lawsuit pertains to securities purchased between February 27, 2023, and November 4, 2025, and investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][5]. - Investors wishing to serve as lead plaintiff must file their motion by January 16, 2026, and a lead plaintiff acts on behalf of other class members in directing the litigation [1][3]. Group 2: Allegations Against Perrigo - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment and required substantial capital expenditures beyond stated estimates [5]. - It is claimed that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow, and that positive statements about the company's business were materially misleading [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, noting its history of achieving significant settlements for investors, including over $438 million in 2019 alone [4]. - The firm has been recognized for its leadership in securities class action settlements, being ranked No. 1 by ISS Securities Class Action Services in 2017 and consistently in the top 4 since 2013 [4].

Core Viewpoint - Rosen Law Firm is encouraging investors of Inspire Medical Systems, Inc. to secure legal counsel before the January 5, 2026 deadline for a class action lawsuit related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the Inspire Medical Systems, Inc. stock is from August 6, 2024, to August 4, 2025, inclusive [2]. - Investors who purchased common stock during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by January 5, 2026 [4]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience [5]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [5]. Group 3: Case Allegations - The lawsuit alleges that Inspire Medical misrepresented key facts about its Inspire V sleep apnea device, including market demand and necessary steps for its launch [6]. - Defendants are accused of issuing materially false and misleading statements that led investors to believe in strong demand for the device, resulting in investor damages when the truth was revealed [6].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Freeport-McMoRan Inc. securities for the period between February 15, 2022, and September 24, 2025, due to alleged misleading statements and safety issues at the Grasberg Block Cave mine in Indonesia [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Freeport-McMoRan did not ensure adequate safety at its Grasberg Block Cave mine, leading to heightened risks for workers [5]. - Allegations include that the company failed to disclose risks related to regulatory, litigation, and reputational issues, which resulted in materially false and misleading statements about its business and operations [5]. - Investors are encouraged to join the class action and may be entitled to compensation without upfront fees through a contingency fee arrangement [2][3]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019, and has been recognized for its performance in securities class action settlements [4]. - Investors can join the class action by submitting a form or contacting the firm directly for more information [3][6].

Core Viewpoint - Rosen Law Firm has initiated a class action lawsuit on behalf of investors in Primo Brands Corporation and Primo Water Corporation, alleging misrepresentation and failure to disclose key facts regarding the merger between the two companies, which led to investor losses during the specified Class Period [2][6]. Group 1: Class Action Details - The class action lawsuit covers purchasers of common stock of Primo Water Corporation from June 17, 2024, to November 8, 2024, and purchasers of common stock of Primo Brands Corporation from November 11, 2024, to November 6, 2025 [2]. - Investors who purchased securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A lead plaintiff must file a motion with the Court by January 12, 2026, to represent other class members in the litigation [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm is recognized for its success in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [5]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [5]. - The founding partner, Laurence Rosen, was named a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and recognition in the field [5]. Group 3: Case Specifics - The lawsuit claims that the merger between Primo Water and BlueTriton Brands was misrepresented, with defendants allegedly providing false statements about the merger's progress and expected benefits, leading to investor damages when the truth was revealed [6].

Core Viewpoint - Rosen Law Firm is urging investors of CarMax, Inc. to secure legal counsel before the January 2, 2026 deadline related to a securities class action lawsuit [2][4]. Group 1: Class Action Details - The class action pertains to CarMax securities purchased between June 20, 2025, and November 5, 2025, and aims to address alleged misleading statements made by the company during this period [2][6]. - The lawsuit claims that CarMax's growth prospects were overstated, attributing earlier growth to temporary factors rather than sustainable business practices [6]. Group 2: Legal Representation - Investors can join the class action without incurring out-of-pocket fees through a contingency fee arrangement [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering significant settlements for investors [5]. Group 3: Next Steps for Investors - Interested investors are encouraged to visit the Rosen Law Firm's website or contact them directly for more information on joining the class action [4][7]. - It is noted that no class has been certified yet, and investors have the option to remain absent or select their own counsel [8].

Core Viewpoint - Rosen Law Firm is urging investors of Sina Corporation who sold shares during the merger period to take action before the November 18, 2025 deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - Investors who sold ordinary shares of Sina Corporation between October 13, 2020, and March 22, 2021, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 18, 2025 [3]. - The lawsuit alleges that defendants engaged in a fraudulent scheme to depress the value of Sina's shares to avoid paying a fair price during the merger [5]. Group 2: Allegations Against Defendants - The lawsuit claims that the defendants misrepresented and omitted material information in Sina's proxy materials, which were essential for shareholders to make informed decisions regarding the merger [5]. - Specific allegations include the concealment of the true value of Sina's investment in TuSimple and that the merger offer of $43.30 per share significantly undervalued Sina's ordinary shares [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].